CD133 has been shown to be in part co-expressed with ABCB5 and CD271 [23–27], and has been used as a stem cell and cancer stem cell marker in melanoma [4, 28, 29], glioblastoma [30], colorectal cancer [31, 32] and others. Here, NGFR is linked to melanoma.